首页> 美国卫生研究院文献>Deutschesrzteblatt International >Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

【2h】

Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

机译：非维生素K拮抗剂口服抗凝剂（NOAC）作为肿瘤相关静脉血栓栓塞的替代治疗选择

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe risk of venous thromboembolism (VTE) is 4 to 7 times higher in cancer patients than in the normal population. Moreover, cancer patients who take anticoagulants suffer more frequently from hemorrhagic complications and VTE recurrences. Patients often find low-molecular-weight heparin (LMWH) treatment unpleasant; approximately 20% stop taking LMWH during the first six months of treatment.

机译：背景癌症患者的静脉血栓栓塞（VTE）风险是正常人群的4至7倍。此外，服用抗凝剂的癌症患者更常发生出血并发症和VTE复发。患者经常发现低分子量肝素（LMWH）治疗令人不快；在治疗的前六个月中，约有20％停止服用LMWH。

著录项

期刊名称 Deutschesrzteblatt International
作者
Jan Beyer-Westendorf; Robert Klamroth; Stephan Kreher; Florian Langer; Axel Matzdorff; Hanno Riess;
展开▼
作者单位

展开▼
年(卷),期 2019(116),3
年度 2019
页码 31–38
总页数 9
原文格式 PDF
正文语种
中图分类基础医学;
关键词

相似文献

外文文献
中文文献
专利

1. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group [J] . Pharithi Rebabonye B., Ranganathan Deepti, OBrien Jim, Irish journal of medical science . 2019,第1期

机译：处方是否正确？非瓣膜心房颤动患者的非维生素K拮抗剂抗凝血剂（NOAC）处方述评。心房颤动和卒中中非维生素K口腔抗凝血剂的心房颤动和评价安全规定（安全Noacs）组
2. Treatment of Venous Thromboembolism in the Era of Non-Vitamin K Antagonist Oral Anticoagulants [J] . Noppacharn Uaprasert Journal of the Medical Association of Thailand =: Chotmaihet thangphaet . 2015,第Suppla1期

机译：非维生素K拮抗剂口服抗凝剂时代的静脉血栓栓塞治疗
3. Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study [J] . Sad?k Volkan Emren, Mehdi Zoghi, Rida Berilgen, Bosnian Journal of Basic Medical Sciences . 2018,第2期

机译：非维生素K拮抗剂口服抗凝剂（NOAC）每日一次或两次给药对非瓣膜性房颤患者的安全性：一项NOAC-TR研究
4. Development and Assessment of RecosDoc-MTeV to Improve the Quality of Direct Oral Anticoagulant Prescription for Venous Thromboembolic Disease. [C] . Brigitte Séroussi, Houda Ouarrirh, Isma?l Elalamy, MEDINFO . 2019

机译：RecoSdoc-MTEV的开发和评估改善静脉血栓栓塞术治疗直接口服抗凝药物的质量。
5. The Bleeding Risk of Non-Vitamin K Antagonist Oral Anticoagulants in Cirrhotic Patients: A Systematic Review and Meta-Analysis [D] . Go, Rafael Francisco C. 2020

机译：肝硬化患者中非维生素K拮抗剂口腔抗凝剂的出血风险：系统审查和荟萃分析
6. Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes [O] . Torben Bjerregaard Larsen, Peter Brønnum Nielsen, Flemming Skjøth, -1

机译：非维生素K拮抗剂口服抗凝剂和癌症患者静脉血栓栓塞的治疗：安全性和有效性结果的半系统评价和Meta分析
7. Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism [O] . Jan Beyer-Westendorf, Robert Klamroth, Stephan Kreher, 2019

机译：非维生素K拮抗剂口服抗凝血剂（NOAC）作为肿瘤相关静脉血栓栓塞中的替代治疗选择

Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

摘要

著录项

相似文献

相关主题

期刊订阅